ArticleCureus2025
FOCAD Gene Defect Resulting in Rapidly Progressing Neonatal Liver Cirrhosis Requiring Transplant.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A novel homozygous splice-site variant in theFrontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In children, cirrhosis is rare and most commonly associated with biliary atresia and other metabolic or genetic conditions. We report a rare case of a preterm infant who developed severe liver cirrhosis in the first few months of life, requiring liver transplant at three months of age. She presented with persistent hypoalbuminaemia, peripheral oedema, ascites, metabolic bone disease with fractures, coagulopathies, and anaemia. She subsequently developed multiorgan failure and disseminated intravascular coagulation (DIC). Extensive investigation found FOCAD gene defect, compound heterozygous for c.4435del p.Lys1475Asnfs* and exon 6-7 deletion. In conclusion, we hope to contribute to the awareness and growing understanding of FOCAD deficiency in children. This case highlights the importance of early diagnosis and consideration of screening for FOCAD deficiency in cases where the cause for cirrhosis is unknown. More research will be needed to better elucidate the full spectrum of the condition, as well as to establish potential prognostic markers and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.